Sartorius inks deal for Quad's T cell activation tech
Quad Technologies has teamed with Sartorius Stedim Biotech to expand the reach of its T-cell activation reagent for cell and gene therapy production.
Archives for January 12, 2018
CombiGene asks UK CGT Catapult to help make epilepsy gene therapy for trials
CombiGene AB has asked the Cell and Gene Therapy Catapult to develop manufacturing processes for its candidate epilepsy gene therapy, CG01.
VC banks on CAR T through acoustic wave separation firm investment
Venture capital company Dynamk Capital has invested in FloDesign Sonics citing its acoustic wave separation technology’s application in the growing CAR T cell sector.